Related Experiment Video
Updated: Apr 18, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Embolic stroke during apixaban therapy for left atrial appendage thrombus
Masaki Ohyagi1, Kazuha Nakamura1, Mutsufusa Watanabe1
1Department of Internal Medicine, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
Apixaban may increase the risk of mobile or fragile thrombi in the left atrial appendage, potentially leading to stroke. Close monitoring for thromboembolic complications is crucial when using apixaban for existing left atrial appendage thrombus.
Area of Science:
- Cardiology
- Hematology
Background:
- Left atrial appendage (LAA) thrombus is a significant risk factor for cardiogenic thromboembolism in patients with atrial fibrillation (AF).
- Warfarin is a standard anticoagulant for LAA thrombus, but its efficacy and safety profile have limitations.
- Apixaban, a direct oral anticoagulant, has shown superiority over warfarin in preventing stroke in AF patients, with some case reports suggesting LAA thrombus resolution.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Transient Ischemic Attack l: Introduction
Venous Thrombosis I: Introduction

